Background Long-term microvascular and neurologic complicationscause major morbidity and mortality in patients with insulin-dependentdiabetes mellitus (IDDM). We examined whether intensive treatmentwith the goal of maintaining blood glucose concentrations closeto the normal range could decrease the frequency and severityof these complications.
Methods A total of 1441 patients with IDDM -- 726 with no retinopathyat base line (the primary-prevention cohort) and 715 with mildretinopathy (the secondary-intervention cohort) were randomlyassigned to intensive therapy administered either with an externalinsulin pump or by three or more daily insulin injections andguided by frequent blood glucose monitoring or to conventionaltherapy with one or two daily insulin injections. The patientswere followed for a mean of 6.5 years, and the appearance andprogression of retinopathy and other complications were assessedregularly.
Results In the primary-prevention cohort, intensive therapyreduced the adjusted mean risk for the development of retinopathyby 76 percent (95 percent confidence interval, 62 to 85 percent),as compared with conventional therapy. In the secondary-interventioncohort, intensive therapy slowed the progression of retinopathyby 54 percent (95 percent confidence interval, 39 to 66 percent)and reduced the development of proliferative or severe nonproliferativeretinopathy by 47 percent (95 percent confidence interval, 14to 67 percent). In the two cohorts combined, intensive therapyreduced the occurrence of microalbuminuria (urinary albuminexcretion of 40 mg per 24 hours) by 39 percent (95 percentconfidence interval, 21 to 52 percent), that of albuminuria(urinary albumin excretion of 300 mg per 24 hours) by 54 percent(95 percent confidence interval, 19 to 74 percent), and thatof clinical neuropathy by 60 percent (95 percent confidenceinterval, 38 to 74 percent). The chief adverse event associatedwith intensive therapy was a two-to-threefold increase in severehypoglycemia.
Conclusions Intensive therapy effectively delays the onset andslows the progression of diabetic retinopathy, nephropathy,and neuropathy in patients with IDDM.
Source Information
A complete list of the persons and institutions participating in the Diabetes Control and Complications Trial Research Group appears in the Appendix.
Address reprint requests to the DCCT Research Group, Box NDIC/DCCT, Bethesda, MD 20892.
Khavandi, K., Greenstein, A. S., Sonoyama, K., Withers, S., Price, A., Malik, R. A., Heagerty, A. M.
(2008). Myogenic tone and small artery remodelling: insight into diabetic nephropathy. Nephrol Dial Transplant
0: gfn583v1-gfn583
[Full Text]
Levin, A. MD, Hemmelgarn, B. MD PhD, Culleton, B. MD MSc, Tobe, S. MD, McFarlane, P. MD PhD, Ruzicka, M. MD PhD, Burns, K. MD, Manns, B. MD MSc, White, C. MD, Madore, F. MD MSc, Moist, L. MD MSc, Klarenbach, S. MD MSc, Barrett, B. MD MSc, Foley, R. MD MSc, Jindal, K. MD, Senior, P. MBBS PhD, Pannu, N. MD MSc, Shurraw, S. MD, Akbari, A. MD, Cohn, A. MD, Reslerova, M. MD PhD, Deved, V. MD, Mendelssohn, D. MD, Nesrallah, G. MD, Kappel, J. MD, Tonelli, M. MD SM, for the Canadian Society of Nephrology,
(2008). Guidelines for the management of chronic kidney disease. CMAJ
179: 1154-1162
[Full Text]
Ismail, K., Thomas, S. M., Maissi, E., Chalder, T., Schmidt, U., Bartlett, J., Patel, A., Dickens, C. M., Creed, F., Treasure, J.
(2008). Motivational Enhancement Therapy with and without Cognitive Behavior Therapy to Treat Type 1 Diabetes: A Randomized Trial. ANN INTERN MED
149: 708-719
[Abstract][Full Text]
Haneda, M., Morikawa, A.
(2008). Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?. Nephrol Dial Transplant
0: gfn616v1-gfn616
[Full Text]
Dankner, R., Geulayov, G., Olmer, L., Kaplan, G.
(2008). Undetected type 2 diabetes in older adults. Age Ageing
0: afn218v1-afn218
[Abstract][Full Text]
Shani, M., Taylor, T. R., Vinker, S., Lustman, A., Erez, R., Elhayany, A., Lahad, A.
(2008). Characteristics of Diabetics with Poor Glycemic Control Who Achieve Good Control. J Am Board Fam Med
21: 490-496
[Abstract][Full Text]
Halkos, M. E., Lattouf, O. M., Puskas, J. D., Kilgo, P., Cooper, W. A., Morris, C. D., Guyton, R. A., Thourani, V. H.
(2008). Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery. Ann. Thorac. Surg.
86: 1431-1437
[Abstract][Full Text]
Kilpatrick, E. S., Rigby, A. S., Atkin, S. L.
(2008). A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial. Diabetes Care
31: 2198-2202
[Abstract][Full Text]
Buckingham, B., Wilson, D. M., Lecher, T., Hanas, R., Kaiserman, K., Cameron, F.
(2008). Duration of Nocturnal Hypoglycemia Before Seizures. Diabetes Care
31: 2110-2112
[Abstract][Full Text]
So, W.-Y., Wang, Y., Ng, M. C.Y., Yang, X., Ma, R. C.W., Lam, V., Kong, A. P.S., Tong, P. C.Y., Chan, J. C.N.
(2008). Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients. Diabetes Care
31: 2148-2153
[Abstract][Full Text]
Cooke, D. W., Plotnick, L.
(2008). Type 1 Diabetes Mellitus in Pediatrics. Pediatr. Rev.
29: 374-385
[Full Text]
Zheng, S., Carlson, E. C., Yang, L., Kralik, P. M., Huang, Y., Epstein, P. N.
(2008). Podocyte-Specific Overexpression of the Antioxidant Metallothionein Reduces Diabetic Nephropathy. J. Am. Soc. Nephrol.
19: 2077-2085
[Abstract][Full Text]
Shibata, T., Naruse, K., Kamiya, H., Kozakae, M., Kondo, M., Yasuda, Y., Nakamura, N., Ota, K., Tosaki, T., Matsuki, T., Nakashima, E., Hamada, Y., Oiso, Y., Nakamura, J.
(2008). Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats. Diabetes
57: 3099-3107
[Abstract][Full Text]
Sacks, D. B.
(2008). Translating Hemoglobin A1c into Average Blood Glucose: Implications for Clinical Chemistry. Clin. Chem.
54: 1756-1758
[Full Text]
Song, H. K., Lee, M. H., Kim, B. K., Park, Y. G., Ko, G. J., Kang, Y. S., Han, J. Y., Han, S. Y., Han, K. H., Kim, H. K., Cha, D. R.
(2008). Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am. J. Physiol. Renal Physiol.
295: F1485-F1494
[Abstract][Full Text]
Deshpande, A. D, Harris-Hayes, M., Schootman, M.
(2008). Epidemiology of Diabetes and Diabetes-Related Complications. ptjournal
88: 1254-1264
[Abstract][Full Text]
Evans, J. D, Jacobs, T. F, Evans, E. W
(2008). Role of Acetyl-L-Carnitine in the Treatment of Diabetic Peripheral Neuropathy. The Annals of Pharmacotherapy
42: 1686-1691
[Abstract][Full Text]
Faustman, D. L.
(2008). Immunotherapy on Trial for New-Onset Type 1 Diabetes. NEJM
359: 1956-1958
[Full Text]
Ludvigsson, J., Faresjo, M., Hjorth, M., Axelsson, S., Cheramy, M., Pihl, M., Vaarala, O., Forsander, G., Ivarsson, S., Johansson, C., Lindh, A., Nilsson, N.-O., Aman, J., Ortqvist, E., Zerhouni, P., Casas, R.
(2008). GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes. NEJM
359: 1909-1920
[Abstract][Full Text]
Nathan, D. M.
(2008). Glycemic Management of Type 2 Diabetes: How Tight Is Right and How to Get There. Arch Intern Med
168: 2064-2066
[Full Text]
Esposito, K., Ciotola, M., Maiorino, M. I., Gualdiero, R., Schisano, B., Ceriello, A., Beneduce, F., Feola, G., Giugliano, D.
(2008). Addition of Neutral Protamine Lispro Insulin or Insulin Glargine to Oral Type 2 Diabetes Regimens for Patients with Suboptimal Glycemic Control: A Randomized Trial. ANN INTERN MED
149: 531-539
[Abstract][Full Text]
Majumdar, S., Barrett, E.
(2008). Newer Insulins in Search of a Niche. ANN INTERN MED
149: 586-588
[Full Text]
Saunders, S.A., Wallymhamed, M., Macfarlane, I.A.
(2008). Improvements in glycaemic control and cardiovascular risk factors in a cohort of patients with type 1 diabetes over a 5-year period. QJM
0: hcn125v2-hcn125
[Abstract][Full Text]
The Juvenile Diabetes Research Foundation Continuo,
(2008). Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. NEJM
359: 1464-1476
[Abstract][Full Text]
Maeda, S.
(2008). Review: Genetics of diabetic nephropathy. Therapeutic Advances in Cardiovascular Disease
2: 363-371
[Abstract]
Anaya, J. P., Rivera, J. O., Lawson, K., Garcia, J., Luna, J. Jr., Ortiz, M.
(2008). Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm
65: 1841-1845
[Abstract][Full Text]
Odom, J., Williamson, B., Carter, L.
(2008). Rosiglitazone and pioglitazone in the treatment of diabetes mellitus. Am J Health Syst Pharm
65: 1846-1850
[Full Text]
Fowler, M. J.
(2008). Hypoglycemia. Clin. Diabetes
26: 170-173
[Full Text]
Perlmuter, L. C., Flanagan, B. P., Shah, P. H., Singh, S. P.
(2008). Glycemic Control and Hypoglycemia: Is the loser the winner?. Diabetes Care
31: 2072-2076
[Full Text]
Mealey, B. L.
(2008). The Interactions Between Physicians and Dentists in Managing the Care of Patients With Diabetes Mellitus. Journal of the American Dental Association
139: 4S-7S
[Full Text]
Kidambi, S., Patel, S. B.
(2008). Diabetes Mellitus: Considerations for Dentistry. Journal of the American Dental Association
139: 8S-18S
[Abstract][Full Text]
Gill, G., Gebrekidan, A., English, P., Wile, D., Tesfaye, S.
(2008). Diabetic complications and glycaemic control in remote North Africa. QJM
101: 793-798
[Abstract][Full Text]
Huttner, S., Graefe-Mody, E. U., Withopf, B., Ring, A., Dugi, K. A.
(2008). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase 4, in Healthy Male Volunteers. J Clin Pharmacol
48: 1171-1178
[Abstract][Full Text]
Musen, G., Jacobson, A. M., Ryan, C. M., Cleary, P. A., Waberski, B. H., Weinger, K., Dahms, W., Bayless, M., Silvers, N., Harth, J., White, N., the Diabetes Control and Complications Trial/Epide,
(2008). Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial. Diabetes Care
31: 1933-1938
[Abstract][Full Text]
Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., and the DCCT/EDIC Cohort Study Group,
(2008). Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications. Diabetes Care
31: 2006-2012
[Abstract][Full Text]
Han, B. G., Hao, C.-M., Tchekneva, E. E., Wang, Y.-Y., Lee, C. A., Ebrahim, B., Harris, R. C., Kern, T. S., Wasserman, D. H., Breyer, M. D., Qi, Z.
(2008). Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. Am. J. Physiol. Endocrinol. Metab.
295: E981-E986
[Abstract][Full Text]
Maile, L. A., Capps, B. E., Miller, E. C., Aday, A. W., Clemmons, D. R.
(2008). Integrin-Associated Protein Association With Src Homology 2 Domain Containing Tyrosine Phosphatase Substrate 1 Regulates IGF-I Signaling In Vivo. Diabetes
57: 2637-2643
[Abstract][Full Text]
Tan, J., Yang, S., Cai, J., Guo, J., Huang, L., Wu, Z., Chen, J., Liao, L.
(2008). Simultaneous Islet and Kidney Transplantation in Seven Patients With Type 1 Diabetes and End-Stage Renal Disease Using a Glucocorticoid-Free Immunosuppressive Regimen With Alemtuzumab Induction. Diabetes
57: 2666-2671
[Abstract][Full Text]
Kottgen, A., Hwang, S.-J., Rampersaud, E., Coresh, J., North, K. E., Pankow, J. S., Meigs, J. B., Florez, J. C., Parsa, A., Levy, D., Boerwinkle, E., Shuldiner, A. R., Fox, C. S., Kao, W.H. L.
(2008). TCF7L2 Variants Associate with CKD Progression and Renal Function in Population-Based Cohorts. J. Am. Soc. Nephrol.
19: 1989-1999
[Abstract][Full Text]
de Boer, I. H., Kestenbaum, B., Rue, T. C., Steffes, M. W., Cleary, P. A., Molitch, M. E., Lachin, J. M., Weiss, N. S., Brunzell, J. D., for the Diabetes Control and Complications Trial (,
(2008). Insulin Therapy, Hyperglycemia, and Hypertension in Type 1 Diabetes Mellitus. Arch Intern Med
168: 1867-1873
[Abstract][Full Text]
Kern, T. S., Barber, A. J.
(2008). Retinal ganglion cells in diabetes. J. Physiol.
586: 4401-4408
[Abstract][Full Text]
Pan, Y., Guo, L. L., Jin, H. M.
(2008). Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr.
88: 660-666
[Abstract][Full Text]
Patasi, B., Conway, J. R.
(2008). Enhancing diabetes care in family practice: A flow sheet. cfp
54: 1237-1238
[Full Text]
Sako, T., Mori, A., Lee, P., Takahashi, T., Izawa, T., Karasawa, S., Furuuchi, M., Azakami, D., Mizukoshi, M., Mizutani, H., Kiyosawa, Y., Arai, T.
(2008). Diagnostic significance of serum glycated albumin in diabetic dogs. jvdi
20: 634-638
[Abstract][Full Text]
Halkos, M. E., Puskas, J. D., Lattouf, O. M., Kilgo, P., Kerendi, F., Song, H. K., Guyton, R. A., Thourani, V. H.
(2008). Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg.
136: 631-640
[Abstract][Full Text]
Finucane, M. L., McMullen, C. K.
(2008). Making Diabetes Self-management Education Culturally Relevant for Filipino Americans in Hawaii. The Diabetes Educator
34: 841-853
[Abstract][Full Text]
Iqbal, N., Morgan, C., Maksoud, H., Idris, I.
(2008). Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes. Ann Clin Biochem
45: 504-507
[Abstract][Full Text]
Nikkanen, T., Timonen, M., Ylitalo, K., Timonen, O., Keinanen-Kiukaanniemi, S., Rajala, U.
(2008). Quality of diabetes care among patients managed by teleconsultation. J Telemed Telecare
14: 295-299
[Abstract][Full Text]
Farley, T. F., Mandava, N., Prall, F. R., Carsky, C.
(2008). Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photography. Ann Fam Med
6: 428-434
[Abstract][Full Text]
Sherwin, R. S.
(2008). Bringing Light to the Dark Side of Insulin: A Journey Across the Blood-Brain Barrier. Diabetes
57: 2259-2268
[Full Text]
Kilpatrick, E S
(2008). Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J. Clin. Pathol.
61: 977-982
[Abstract][Full Text]
Berg, A H, Sacks, D B
(2008). Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony. J. Clin. Pathol.
61: 983-987
[Abstract][Full Text]
Kowluru, R. A., Kanwar, M., Chan, P.-S., Zhang, J. P.
(2008). Inhibition of Retinopathy and Retinal Metabolic Abnormalities in Diabetic Rats With AREDS-Based Micronutrients. Arch Ophthalmol
126: 1266-1272
[Abstract][Full Text]
Thiebaud, P., Demand, M., Wolf, S. A., Alipuria, L. L., Ye, Q., Gutierrez, P. R.
(2008). Impact of Disease Management on Utilization and Adherence With Drugs and Tests: The case of diabetes treatment in the Florida: A Healthy State (FAHS) program. Diabetes Care
31: 1717-1722
[Abstract][Full Text]
Hall, P. A., Coons, M. J., Vallis, T. M.
(2008). Anxious Temperament and Disease Progression at Diagnosis: The Case of Type 2 Diabetes. Psychosom. Med.
70: 837-843
[Abstract][Full Text]
Melamed, M. L., Bauer, C., Hostetter, T. H.
(2008). eGFR: Is It Ready for Early Identification of CKD?. CJASN
3: 1569-1572
[Abstract][Full Text]
Hartman, I.
(2008). Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence. Clin Med Res
6: 54-67
[Abstract][Full Text]
Khera, P. K., Joiner, C. H., Carruthers, A., Lindsell, C. J., Smith, E. P., Franco, R. S., Holmes, Y. R., Cohen, R. M.
(2008). Evidence for Interindividual Heterogeneity in the Glucose Gradient Across the Human Red Blood Cell Membrane and Its Relationship to Hemoglobin Glycation. Diabetes
57: 2445-2452
[Abstract][Full Text]
Kile, M. L., Christiani, D. C.
(2008). Environmental Arsenic Exposure and Diabetes. JAMA
300: 845-846
[Full Text]
Wilper, A. P., Woolhandler, S., Lasser, K. E., McCormick, D., Bor, D. H., Himmelstein, D. U.
(2008). A National Study of Chronic Disease Prevalence and Access to Care in Uninsured U.S. Adults. ANN INTERN MED
149: 170-176
[Abstract][Full Text]
Duke, D. C., Geffken, G. R., Lewin, A. B., Williams, L. B., Storch, E. A., Silverstein, J. H.
(2008). Glycemic Control in Youth with Type 1 Diabetes: Family Predictors and Mediators. J Pediatr Psychol
33: 719-727
[Abstract][Full Text]
Goldman, R. E., Sanchez-Hernandez, M., Ross-Degnan, D., Piette, J. D., Trinacty, C. M., Simon, S. R.
(2008). Developing an automated speech-recognition telephone diabetes intervention. Int J Qual Health Care
20: 264-270
[Abstract][Full Text]
Fonseca, V. A., Rosenstock, J., Wang, A. C., Truitt, K. E., Jones, M. R.
(2008). Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy. Diabetes Care
31: 1479-1484
[Abstract][Full Text]
Kumar, A. F., Gruessner, R. W.G., Seaquist, E. R.
(2008). Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism. Diabetes Care
31: 1639-1643
[Abstract][Full Text]
O'Connell, M. A., Gilbertson, H. R., Donath, S. M., Cameron, F. J.
(2008). Optimizing Postprandial Glycemia in Pediatric Patients With Type 1 Diabetes Using Insulin Pump Therapy: Impact of glycemic index and prandial bolus type. Diabetes Care
31: 1491-1495
[Abstract][Full Text]
Hietala, K., Forsblom, C., Summanen, P., Groop, P.-H., on behalf of the FinnDiane Study Group,
(2008). Heritability of Proliferative Diabetic Retinopathy. Diabetes
57: 2176-2180
[Abstract][Full Text]
Geistanger, A., Arends, S., Berding, C., Hoshino, T., Jeppsson, J.-O., Little, R., Siebelder, C., Weykamp, C., on behalf of the IFCC Working Group on Standardiza,
(2008). Statistical Methods for Monitoring the Relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan, and Sweden. Clin. Chem.
54: 1379-1385
[Abstract][Full Text]
Little, R. R., Rohlfing, C. L., Hanson, S., Connolly, S., Higgins, T., Weykamp, C. W., D'Costa, M., Luzzi, V., Owen, W. E., Roberts, W. L.
(2008). Effects of Hemoglobin (Hb) E and HbD Traits on Measurements of Glycated Hb (HbA1c) by 23 Methods. Clin. Chem.
54: 1277-1282
[Abstract][Full Text]
Goldberg, R. B., Fonseca, V. A., Truitt, K. E., Jones, M. R.
(2008). Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy. Arch Intern Med
168: 1531-1540
[Abstract][Full Text]
Davis, E. M., Christensen, C. M., Nystrom, K. K., Foral, P. A., Destache, C.
(2008). Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm
65: 1347-1357
[Abstract][Full Text]
Yoshida, M., Booth, S. L, Meigs, J. B, Saltzman, E., Jacques, P. F
(2008). Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am. J. Clin. Nutr.
88: 210-215
[Abstract][Full Text]
Rhee, M. K., Ziemer, D. C., Caudle, J., Kolm, P., Phillips, L. S.
(2008). Use of a Uniform Treatment Algorithm Abolishes Racial Disparities in Glycemic Control. The Diabetes Educator
34: 655-663
[Abstract][Full Text]
Ginde, A. A., Pallin, D. J., Camargo, C. A. Jr
(2008). Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia. The Diabetes Educator
34: 683-691
[Abstract][Full Text]
Macdonald, D. R, Hanson, A. M, Holland, M. R, Singh, B. M
(2008). Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis. Ann Clin Biochem
45: 421-425
[Abstract][Full Text]
Fowler, M. J.
(2008). Diabetes Devices. Clin. Diabetes
26: 130-133
[Full Text]
Freeman, J. S., Capuzzi, D. M., Rockwell, K.
(2008). Leveraging Continuous Glucose Monitoring in the Clinical Management of Adjunctive Pramlintide Therapy. Clin. Diabetes
26: 134-137
[Full Text]
Triplitt, C., Alvarez, C. A.
(2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr.
21: 177-189
[Abstract][Full Text]
Ramser, K. L., Sprabery, L. R., George, C. M., Hamann, G. L., Vallejo, V. A., Dorko, C. S., Kuhl, D. A.
(2008). Physician-Pharmacist Collaboration in the Management of Patients With Diabetes Resistant to Usual Care. Diabetes Spectr.
21: 209-214
[Full Text]
Huang, E. S., Zhang, Q., Gandra, N., Chin, M. H., Meltzer, D. O.
(2008). The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis. ANN INTERN MED
149: 11-19
[Abstract][Full Text]
Bergenstal, R. M., Johnson, M., Powers, M. A., Wynne, A., Vlajnic, A., Hollander, P., Rendell, M.
(2008). Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care
31: 1305-1310
[Abstract][Full Text]
Rossetti, P., Porcellati, F., Busciantella Ricci, N., Candeloro, P., Cioli, P., Nair, K. S., Santeusanio, F., Bolli, G. B., Fanelli, C. G.
(2008). Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People. Diabetes
57: 1905-1917
[Abstract][Full Text]
Hilliard, M. E., Goeke-Morey, M., Cogen, F. R., Henderson, C., Streisand, R.
(2008). Predictors of Diabetes-related Quality of Life after Transitioning to the Insulin Pump. J Pediatr Psychol
0: jsn062v2-jsn062
[Abstract][Full Text]
Dabir, P., Marinic, T. E., Krukovets, I., Stenina, O. I.
(2008). Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells. Circ. Res.
102: 1558-1565
[Abstract][Full Text]
Norris, S. L., Kansagara, D., Bougatsos, C., Fu, R.
(2008). Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
148: 855-868
[Abstract][Full Text]
Suying Li, , Jiannong Liu, , Gilbertson, D., McBean, M., Dowd, B., Collins, A.
(2008). An Instrumental Variable Analysis of the Impact of Practice Guidelines on Improving Quality of Care and Diabetes-Related Outcomes in the Elderly Medicare Population. American Journal of Medical Quality
23: 222-230
[Abstract]
Meece, J.
(2008). Effect of insulin pen devices on the management of diabetes mellitus. Am J Health Syst Pharm
65: 1076-1082
[Full Text]
Phillips, B. E., Cancel, L., Tarbell, J. M., Antonetti, D. A.
(2008). Occludin Independently Regulates Permeability under Hydrostatic Pressure and Cell Division in Retinal Pigment Epithelial Cells. IOVS
49: 2568-2576
[Abstract][Full Text]
Wu, M., Chen, Y., Wilson, K., Chirindel, A., Ihnat, M. A., Yu, Y., Boulton, M. E., Szweda, L. I., Ma, J.-X., Lyons, T. J.
(2008). Intraretinal Leakage and Oxidation of LDL in Diabetic Retinopathy. IOVS
49: 2679-2685
[Abstract][Full Text]
Helgeson, V. S., Reynolds, K. A., Siminerio, L., Escobar, O., Becker, D.
(2008). Parent and Adolescent Distribution of Responsibility for Diabetes Self-care: Links to Health Outcomes. J Pediatr Psychol
33: 497-508
[Abstract][Full Text]
Balagopal, P., Kamalamma, N., Patel, T. G., Misra, R.
(2008). A Community-Based Diabetes Prevention and Management Education Program in a Rural Village in India. Diabetes Care
31: 1097-1104
[Abstract][Full Text]
Kaiser, P., Akerboom, T., Molnar, P., Reinauer, H.
(2008). Modified HPLC-Electrospray Ionization/Mass Spectrometry Method for HbA1c Based on IFCC Reference Measurement Procedure. Clin. Chem.
54: 1018-1022
[Abstract][Full Text]
O'Kane, M. J, Bunting, B., Copeland, M., Coates, V. E, on behalf of the ESMON study group,
(2008). Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ
336: 1174-1177
[Abstract][Full Text]
40 mg per 24 hours) by 39 percent (95 percent confidence interval, 21 to 52 percent), that of albuminuria (urinary albumin excretion of 
